Mondelez International Inc (NASDAQ: MDLZ): The Best-Of-Breed For Investing?

Currently, there are 1.29B common shares owned by the public and among those 1.29B shares have been available to trade.

The company’s stock has a 5-day price change of 1.82% and 5.36% over the past three months. MDLZ shares are trading 3.59% year to date (YTD), with the 12-month market performance up to 14.57% higher. It has a 12-month low price of $53.95 and touched a high of $76.06 over the same period. MDLZ has an average intraday trading volume of 8.07 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.89%, 2.53%, and 4.14% respectively.

Institutional ownership of Mondelez International Inc (NASDAQ: MDLZ) shares accounts for 84.03% of the company’s 1.29B shares outstanding.

It has a market capitalization of $88.60B and a beta (3y monthly) value of 0.50. The stock’s trailing 12-month PE ratio is 25.43, while the earnings-per-share (ttm) stands at $2.69. The company has a PEG of 9.67 and a Quick Ratio of 0.40 with the debt-to-equity ratio at 0.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.43% over the week and 1.07% over the month.

Earnings per share for the fiscal year are expected to decrease by -10.27%, and 9.78% over the next financial year. EPS should shrink at an annualized rate of 2.63% over the next five years, compared to 4.90% over the past 5-year period.

Looking at the support for the MDLZ, a number of firms have released research notes about the stock. Wells Fargo stated their Overweight rating for the stock in a research note on June 20, 2025, with the firm’s price target at $78. DA Davidson coverage for the Mondelez International Inc (MDLZ) stock in a research note released on April 24, 2025 offered a Neutral rating with a price target of $68. Piper Sandler was of a view on March 27, 2025 that the stock is Neutral, while Morgan Stanley gave the stock Overweight rating on March 24, 2025, issuing a price target of $69. Argus on their part issued Hold rating on February 21, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.